{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:50:51Z","timestamp":1792788651367,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T00:00:00Z","timestamp":1620518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,5,9]],"date-time":"2021-05-09T00:00:00Z","timestamp":1620518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["272983813-TRR179"],"award-info":[{"award-number":["272983813-TRR179"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR237"],"award-info":[{"award-number":["TRR237"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALIOS BioPharma"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2021,6,4]]},"DOI":"10.15252\/embr.201949568","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T02:55:05Z","timestamp":1620615305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7342-9751","authenticated-orcid":false,"given":"Daniela","family":"Stadler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"K\u00e4chele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha N","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4080-2468","authenticated-orcid":false,"given":"Christian","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firat","family":"Nebioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Bester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Lasitschka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-5657","authenticated-orcid":false,"given":"Marc","family":"Ringelhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunkyu","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Min","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Geerlof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten A","family":"van de Klundert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen M","family":"Wettengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Heikenw\u00e4lder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-9307","authenticated-orcid":false,"given":"Ralf","family":"Bartenschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0166-1367","authenticated-orcid":false,"given":"Andreas","family":"Pichlmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-1911","authenticated-orcid":false,"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,9]]},"reference":[{"key":"BFEMBR201949568_CR1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/gutjnl-2016-312162","volume":"67","author":"L Allweiss","year":"2018","unstructured":"Allweiss L, Volz T, Giersch K, Kah J, Raffa G, Petersen J, Lohse AW, Beninati C, Pollicino T, Urban S et al (2018) Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo. Gut 67: 542\u2013552","journal-title":"Gut"},{"key":"BFEMBR201949568_CR2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1172\/JCI58847","volume":"122","author":"L Belloni","year":"2012","unstructured":"Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T, Petersen J, Raimondo G, Dandri M, Levrero M (2012) IFN-\u03b1 inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest 122: 529\u2013537","journal-title":"J Clin Invest"},{"key":"BFEMBR201949568_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 57: 289\u2013300","journal-title":"J R Stat Soc Series B"},{"key":"BFEMBR201949568_CR4","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1136\/gutjnl-2011-301073","volume":"61","author":"A Bertoletti","year":"2012","unstructured":"Bertoletti A, Ferrari C (2012) Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 61: 1754\u20131764","journal-title":"Gut"},{"key":"BFEMBR201949568_CR5","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.1074\/jbc.275.11.7451","volume":"275","author":"T Bessho","year":"2000","unstructured":"Bessho T, Sancar A (2000) Human DNA damage checkpoint protein hRAD9 Is a 3\u2032 to 5\u2032 exonuclease. J Biol Chem 275: 7451\u20137454","journal-title":"J Biol Chem"},{"key":"BFEMBR201949568_CR6","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.str.2015.03.016","volume":"23","author":"MF Bohn","year":"2015","unstructured":"Bohn MF, Shandilya SM, Silvas TV, Nalivaika EA, Kouno T, Kelch BA, Ryder SP, Kurt-Yilmaz N, Somasundaran M, Schiffer CA (2015) The ssDNA mutator APOBEC3A is regulated by cooperative dimerization. Structure 23: 903\u2013911","journal-title":"Structure"},{"key":"BFEMBR201949568_CR7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2121-11-28","volume":"11","author":"O Burnicka-Turek","year":"2010","unstructured":"Burnicka-Turek O, Kata A, Buyandelger B, Ebermann L, Kramann N, Burfeind P, Hoyer-Fender S, Engel W, Adham IM (2010) Pelota interacts with HAX1, EIF3G and SRPX and the resulting protein complexes are associated with the actin cytoskeleton. BMC Cell Biol 11: 28","journal-title":"BMC Cell Biol"},{"key":"BFEMBR201949568_CR8","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1128\/AAC.00473-12","volume":"56","author":"D Cai","year":"2012","unstructured":"Cai D, Mills C, Yu W, Yan R, Aldrich CE, Saputelli JR, Mason WS, Xu X, Guo J-T, Block TM et al (2012) Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation. Antimicrob Agents Chemother 56: 4277\u20134288","journal-title":"Antimicrob Agents Chemother"},{"key":"BFEMBR201949568_CR9","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1128\/JVI.72.2.1043-1051.1998","volume":"72","author":"MK Chelbi-Alix","year":"1998","unstructured":"Chelbi-Alix MK, Quignon F, Pelicano L, Koken MH, de The H (1998) Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol 72: 1043\u20131051","journal-title":"J Virol"},{"key":"BFEMBR201949568_CR10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.tcb.2007.09.006","volume":"17","author":"H-W Chen","year":"2007","unstructured":"Chen H-W, Koehler CM, Teitell MA (2007) Human polynucleotide phosphorylase: location matters. Trends Cell Biol 17: 600\u2013608","journal-title":"Trends Cell Biol"},{"key":"BFEMBR201949568_CR11","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1172\/JCI135616","volume":"130","author":"X Cheng","year":"2020","unstructured":"Cheng X, Uchida T, Xia Y, Umarova R, Liu C-J, Chen P-J, Gaggar A, Suri V, M\u00fccke MM, Vermehren J et al (2020) Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection. J Clin Invest 130: 3205\u20133220","journal-title":"J Clin Invest"},{"key":"BFEMBR201949568_CR12","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/j.febslet.2013.07.055","volume":"587","author":"S Chowdhury","year":"2013","unstructured":"Chowdhury S, Kitamura K, Simadu M, Koura M, Muramatsu M (2013) Concerted action of activation-induced cytidine deaminase and uracil-DNA glycosylase reduces covalently closed circular DNA of duck hepatitis B virus. FEBS Lett 587: 3148\u20133152","journal-title":"FEBS Lett"},{"key":"BFEMBR201949568_CR13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","volume":"531","author":"A Decorsi\u00e8re","year":"2016","unstructured":"Decorsi\u00e8re A, Mueller H, van Breugel PC, Abdul F, Gerossier L, Beran RK, Livingston CM, Niu C, Fletcher SP, Hantz O et al (2016) Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor. Nature 531: 386\u2013389","journal-title":"Nature"},{"key":"BFEMBR201949568_CR14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE (2002) Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207\u2013210","journal-title":"Nucleic Acids Res"},{"key":"BFEMBR201949568_CR15","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/jcb.20869","volume":"98","author":"L Espert","year":"2006","unstructured":"Espert L, Eldin P, Gongora C, Bayard B, Harper F, Chelbi-Alix MK, Bertrand E, Degols G, Mechti N (2006) The exonuclease ISG20 mainly localizes in the nucleolus and the Cajal (Coiled) bodies and is associated with nuclear SMN protein-containing complexes. J Cell Biochem 98: 1320\u20131333","journal-title":"J Cell Biochem"},{"key":"BFEMBR201949568_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.gastro.2018.10.032","volume":"156","author":"AJ Gehring","year":"2019","unstructured":"Gehring AJ, Protzer U (2019) Targeting innate and adaptive immune responses to cure chronic HBV infection. Gastroenterology 156: 325\u2013337","journal-title":"Gastroenterology"},{"key":"BFEMBR201949568_CR17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jhep.2015.03.011","volume":"63","author":"K Giersch","year":"2015","unstructured":"Giersch K, Allweiss L, Volz T, Helbig M, Bierwolf J, Lohse AW, Pollok JM, Petersen J, Dandri M, Lutgehetmann M (2015) Hepatitis delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection. J Hepatol 63: 346\u2013353","journal-title":"J Hepatol"},{"key":"BFEMBR201949568_CR18","doi-asserted-by":"crossref","first-page":"19457","DOI":"10.1074\/jbc.272.31.19457","volume":"272","author":"C Gongora","year":"1997","unstructured":"Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A, Mechti N (1997) Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J Biol Chem 272: 19457\u201319463","journal-title":"J Biol Chem"},{"key":"BFEMBR201949568_CR19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","volume":"284","author":"LG Guidotti","year":"1999","unstructured":"Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV (1999) Viral clearance without destruction of infected cells during acute HBV infection. Science 284: 825\u2013829","journal-title":"Science"},{"key":"BFEMBR201949568_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1099\/vir.0.004861-0","volume":"90","author":"O Hantz","year":"2009","unstructured":"Hantz O, Parent R, Durantel D, Gripon P, Guguen-Guillouzo C, Zoulim F (2009) Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J Gen Virol 90: 127\u2013135","journal-title":"J Gen Virol"},{"key":"BFEMBR201949568_CR21","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jhep.2014.06.035","volume":"61","author":"MH Heim","year":"2014","unstructured":"Heim MH, Thimme R (2014) Innate and adaptive immune responses in HCV infections. J Hepatol 61: S14\u201325","journal-title":"J Hepatol"},{"key":"BFEMBR201949568_CR22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/JVI.73.1.474-481.1999","volume":"73","author":"T Heise","year":"1999","unstructured":"Heise T, Guidotti LG, Cavanaugh VJ, Chisari FV (1999) Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol 73: 474\u2013481","journal-title":"J Virol"},{"key":"BFEMBR201949568_CR23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.celrep.2016.01.021","volume":"14","author":"JI Hoopes","year":"2016","unstructured":"Hoopes JI, Cortez LM, Mertz TM, Malc EP, Mieczkowski PA, Roberts SA (2016) APOBEC3A and APOBEC3B preferentially deaminate the lagging strand template during DNA replication. Cell Rep 14: 1273\u20131282","journal-title":"Cell Rep"},{"key":"BFEMBR201949568_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/v9030056","volume":"9","author":"J Hu","year":"2017","unstructured":"Hu J, Liu K (2017) Complete and incomplete hepatitis B virus particles: formation, function, and application. Viruses 9: 56","journal-title":"Viruses"},{"key":"BFEMBR201949568_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/hep.31240","volume":"73","author":"Q Huang","year":"2021","unstructured":"Huang Q, Zhou B, Cai D, Zong Y, Wu Y, Liu S, Mercier A, Guo H, Hou J, Colonno R et al (2021) Rapid turnover of HBV cccDNA indicated by monitoring emergence and reversion of signature-mutation in treated chronic hepatitis B patients. Hepatology 73: 41\u201352","journal-title":"Hepatology"},{"key":"BFEMBR201949568_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008338","volume":"16","author":"H Imam","year":"2020","unstructured":"Imam H, Kim GW, Mir SA, Khan M, Siddiqui A (2020) Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts. PLoS Pathog 16: e1008338","journal-title":"PLoS Pathog"},{"key":"BFEMBR201949568_CR27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/jvh.12192","volume":"20","author":"EM Janahi","year":"2013","unstructured":"Janahi EM, McGarvey MJ (2013) The inhibition of hepatitis B virus by APOBEC cytidine deaminases. J Viral Hepatitis 20: 821\u2013828","journal-title":"J Viral Hepatitis"},{"key":"BFEMBR201949568_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","volume":"365","author":"HLA Janssen","year":"2005","unstructured":"Janssen HLA, van Zonneveld M, Senturk H, Zeuzem S, Akarca US, Cakaloglu Y, Simon C, So TMK, Gerken G, de Man RA et al (2005) Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365: 123\u2013129","journal-title":"Lancet"},{"key":"BFEMBR201949568_CR29","doi-asserted-by":"crossref","first-page":"10588","DOI":"10.1128\/JVI.02489-06","volume":"81","author":"S Jost","year":"2007","unstructured":"Jost S, Turelli P, Mangeat B, Protzer U, Trono D (2007) Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons. J Virol 81: 10588\u201310596","journal-title":"J Virol"},{"key":"BFEMBR201949568_CR30","volume":"9","author":"M Kleine","year":"2014","unstructured":"Kleine M, Riemer M, Krech T, DeTemple D, J\u00e4ger MD, Lehner F, Manns MP, Klempnauer J, Borlak J, Bektas H et al (2014) Explanted diseased livers \u2013 A possible source of metabolic competent primary human hepatocytes. PLoS One 9: e101386","journal-title":"PLoS One"},{"key":"BFEMBR201949568_CR31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","volume":"69","author":"C Ko","year":"2018","unstructured":"Ko C, Chakraborty A, Chou W-M, Hasreiter J, Wettengel JM, Stadler D, Bester R, Asen T, Zhang Ke, Wisskirchen K et al (2018) Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels. J Hepatol 69: 1231\u20131241","journal-title":"J Hepatol"},{"key":"BFEMBR201949568_CR32","first-page":"188","volume":"155","author":"S Koh","year":"2018","unstructured":"Koh S, Kah J, Tham CYL, Yang N, Ceccarello E, Chia A, Chen M, Khakpoor A, Pavesi A, Tan AT et al (2018) Non-lytic lymphocytes engineered to express virus-specific T-cell receptors limit HBV infection by activating APOBEC3. Gastroenterology 155: 188\u2013193","journal-title":"Gastroenterology"},{"key":"BFEMBR201949568_CR33","doi-asserted-by":"crossref","first-page":"68179","DOI":"10.18632\/oncotarget.11907","volume":"7","author":"CR Leong","year":"2016","unstructured":"Leong CR, Funami K, Oshiumi H, Mengao D, Takaki H, Matsumoto M, Aly HH, Watashi K, Chayama K, Seya T (2016) Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of Hepatitis B virus to impede the replication of HBV in vitro and in vivo. Oncotarget 7: 68179\u201368193","journal-title":"Oncotarget"},{"key":"BFEMBR201949568_CR34","doi-asserted-by":"crossref","first-page":"12715","DOI":"10.1038\/s41598-017-13082-z","volume":"7","author":"Y Li","year":"2017","unstructured":"Li Y, Xia Y, Han M, Chen G, Zhang D, Thasler WE, Protzer U, Ning Q (2017) IFN-alpha-mediated base excision repair pathway correlates with antiviral response against hepatitis B virus infection. Sci Rep 7: 12715","journal-title":"Sci Rep"},{"key":"BFEMBR201949568_CR35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.1182015","volume":"327","author":"X Liu","year":"2010","unstructured":"Liu X, Bushnell DA, Wang D, Calero G, Kornberg RD (2010) Structure of an RNA polymerase II\u2013TFIIB complex and the transcription initiation mechanism. Science 327: 206\u2013209","journal-title":"Science"},{"key":"BFEMBR201949568_CR36","volume":"13","author":"Y Liu","year":"2017","unstructured":"Liu Y, Nie H, Mao R, Mitra B, Cai D, Yan R, Guo JT, Block TM, Mechti N, Guo H (2017) Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA. PLoS Pathog 13: e1006296","journal-title":"PLoS Pathog"},{"key":"BFEMBR201949568_CR37","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jmv.23610","volume":"85","author":"X Lu","year":"2013","unstructured":"Lu X, Qin B, Ma Q, Yang C, Gong XY, Chen LM (2013) Differential expression of ISG20 in chronic hepatitis B patients and relation to interferon-alpha therapy response. J Med Virol 85: 1506\u20131512","journal-title":"J Med Virol"},{"key":"BFEMBR201949568_CR38","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","volume":"55","author":"J Lucifora","year":"2011","unstructured":"Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, Levrero M, Zoulim F, Hantz O, Protzer U (2011) Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol 55: 996\u20131003","journal-title":"J Hepatol"},{"key":"BFEMBR201949568_CR39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.23230","volume":"51","author":"J Lucifora","year":"2010","unstructured":"Lucifora J, Durantel D, Testoni B, Hantz O, Levrero M, Zoulim F (2010) Control of hepatitis B virus replication by innate response of HepaRG cells. Hepatology 51: 63\u201372","journal-title":"Hepatology"},{"key":"BFEMBR201949568_CR40","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jhep.2016.02.009","volume":"64","author":"J Lucifora","year":"2016","unstructured":"Lucifora J, Protzer U (2016) Attacking hepatitis B virus cccDNA \u2013 The holy grail to hepatitis B cure. J Hepatol 64: S41\u2013S48","journal-title":"J Hepatol"},{"key":"BFEMBR201949568_CR41","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","volume":"343","author":"J Lucifora","year":"2014","unstructured":"Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, Sprinzl MF, Koppensteiner H, Makowska Z, Volz T et al (2014) Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343: 1221\u20131228","journal-title":"Science"},{"key":"BFEMBR201949568_CR42","first-page":"17940","volume":"9","author":"Q Ma","year":"2016","unstructured":"Ma Q, Qin B, Lu X, Kong L (2016) Interferon stimulated exonuclease gene 20 kDa promotes the activity of interferon-alpha on the inhibition of hepatitis B virus replication via its exonuclease activity. Int J Clin Exp Med 9: 17940\u201317945","journal-title":"Int J Clin Exp Med"},{"key":"BFEMBR201949568_CR43","doi-asserted-by":"crossref","first-page":"22161","DOI":"10.1074\/jbc.M601716200","volume":"281","author":"H Muckenfuss","year":"2006","unstructured":"Muckenfuss H, Hamdorf M, Held U, Perkovic M, L\u00f6wer J, Cichutek K, Flory E, Schumann GG, M\u00fcnk C (2006) APOBEC3 proteins inhibit human LINE-1 retrotransposition. J Biol Chem 281: 22161\u201322172","journal-title":"J Biol Chem"},{"key":"BFEMBR201949568_CR44","doi-asserted-by":"crossref","first-page":"17780","DOI":"10.1073\/pnas.0508913102","volume":"102","author":"JM Murray","year":"2005","unstructured":"Murray JM, Wieland SF, Purcell RH, Chisari FV (2005) Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci USA 102: 17780\u201317785","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201949568_CR45","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bbagrm.2013.03.005","volume":"1829","author":"VK Nagarajan","year":"2013","unstructured":"Nagarajan VK, Jones CI, Newbury SF, Green PJ (2013) XRN 5\u2032 \u2192 3\u2032 exoribonucleases: Structure, mechanisms and functions. Biochim Biophys Acta 1829: 590\u2013603","journal-title":"Biochim Biophys Acta"},{"key":"BFEMBR201949568_CR46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"M Naghavi","year":"2015","unstructured":"Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, Vollset SE, Ozgoren AA, Abdalla S, Abd-Allah F et al (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385: 117\u2013171","journal-title":"Lancet"},{"key":"BFEMBR201949568_CR47","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","volume":"64","author":"M Nassal","year":"2015","unstructured":"Nassal M (2015) HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 64: 1972\u20131984","journal-title":"Gut"},{"key":"BFEMBR201949568_CR48","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1021\/bi010141t","volume":"40","author":"LH Nguyen","year":"2001","unstructured":"Nguyen LH, Espert L, Mechti N, Wilson 3rd DM (2001) The human interferon- and estrogen-regulated ISG20\/HEM45 gene product degrades single-stranded RNA and DNA in vitro. Biochemistry 40: 7174\u20137179","journal-title":"Biochemistry"},{"key":"BFEMBR201949568_CR49","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, Inuganti A, Griss J, Mayer G, Eisenacher M et al (2019) The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res 47: D442\u2013d450","journal-title":"Nucleic Acids Res"},{"key":"BFEMBR201949568_CR50","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1053\/j.gastro.2007.07.021","volume":"133","author":"U Protzer","year":"2007","unstructured":"Protzer U, Seyfried S, Quasdorff M, Sass G, Svorcova M, Webb D, Bohne F, Hosel M, Schirmacher P, Tiegs G (2007) Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 133: 1156\u20131165","journal-title":"Gastroenterology"},{"key":"BFEMBR201949568_CR51","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1873-3468.12058","volume":"590","author":"Y Qiao","year":"2016","unstructured":"Qiao Y, Han X, Guan G, Wu N, Sun J, Pak V, Liang G (2016) TGF-beta triggers HBV cccDNA degradation through AID-dependent deamination. FEBS Lett 590: 419\u2013427","journal-title":"FEBS Lett"},{"key":"BFEMBR201949568_CR52","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber J, Mann M, Ishihama Y (2007) Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc 2: 1896\u20131906","journal-title":"Nat Protoc"},{"key":"BFEMBR201949568_CR53","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","volume":"2","author":"B Rehermann","year":"1996","unstructured":"Rehermann B, Ferrari C, Pasquinelli C, Chisari FV (1996) The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T\u2013lymphocyte response. Nat Med 2: 1104\u20131108","journal-title":"Nat Med"},{"key":"BFEMBR201949568_CR54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/j.gastro.2018.08.061","volume":"156","author":"B Rehermann","year":"2019","unstructured":"Rehermann B, Thimme R (2019) Insights from antiviral therapy into immune responses to hepatitis B and C virus infection. Gastroenterology 156: 369\u2013383","journal-title":"Gastroenterology"},{"key":"BFEMBR201949568_CR55","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43: e47","journal-title":"Nucleic Acids Res"},{"key":"BFEMBR201949568_CR56","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.4254\/wjh.v7.i12.1660","volume":"7","author":"ZNA Said","year":"2015","unstructured":"Said ZNA, Abdelwahab KS (2015) Induced immunity against hepatitis B virus. World J Hepatol 7: 1660\u20131670","journal-title":"World J Hepatol"},{"key":"BFEMBR201949568_CR57","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F (2014) Improved vectors and genome-wide libraries for CRISPR screening. Nat Meth 11: 783\u2013784","journal-title":"Nat Meth"},{"key":"BFEMBR201949568_CR58","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.1021\/ja051306e","volume":"127","author":"P Schanda","year":"2005","unstructured":"Schanda P, Brutscher B (2005) Very fast two-dimensional NMR spectroscopy for real-time investigation of dynamic events in proteins on the time scale of seconds. J Am Chem Soc 127: 8014\u20138015","journal-title":"J Am Chem Soc"},{"key":"BFEMBR201949568_CR59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","volume":"32","author":"WM Schneider","year":"2014","unstructured":"Schneider WM, Chevillotte MD, Rice CM (2014) Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 32: 513\u2013545","journal-title":"Annu Rev Immunol"},{"key":"BFEMBR201949568_CR60","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","volume":"480","author":"C Seeger","year":"2015","unstructured":"Seeger C, Mason WS (2015) Molecular biology of hepatitis B virus infection. Virology 480: 672\u2013686","journal-title":"Virology"},{"key":"BFEMBR201949568_CR61","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi Xi, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG et al (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343: 84\u201387","journal-title":"Science"},{"key":"BFEMBR201949568_CR62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000015667","volume":"90","author":"R Shamsadin","year":"2000","unstructured":"Shamsadin R, Adham IM, von Beust G, Engel W (2000) Molecular cloning, expression and chromosome location of the human pelota gene PELO. Cytogenet Genome Res 90: 75\u201378","journal-title":"Cytogenet Genome Res"},{"key":"BFEMBR201949568_CR63","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.4049\/jimmunol.1501504","volume":"195","author":"S Stavrou","year":"2015","unstructured":"Stavrou S, Ross SR (2015) APOBEC3 proteins in viral immunity. J Immunol 195: 4565\u20134570","journal-title":"J Immunol"},{"key":"BFEMBR201949568_CR64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nsmb.1744","volume":"17","author":"MD Stenglein","year":"2010","unstructured":"Stenglein MD, Burns MB, Li M, Lengyel J, Harris RS (2010) APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat Struct Mol Biol 17: 222\u2013229","journal-title":"Nat Struct Mol Biol"},{"key":"BFEMBR201949568_CR65","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","volume":"99","author":"AI Su","year":"2002","unstructured":"Su AI, Pezacki JP, Wodicka L, Brideau AD, Supekova L, Thimme R, Wieland S, Bukh J, Purcell RH, Schultz PG et al (2002) Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 99: 15669\u201315674","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201949568_CR66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(82)90157-X","volume":"29","author":"J Summers","year":"1982","unstructured":"Summers J, Mason WS (1982) Replication of the genome of a hepatitis B\u2013like virus by reverse transcription of an RNA intermediate. Cell 29: 403\u2013415","journal-title":"Cell"},{"key":"BFEMBR201949568_CR67","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1099\/vir.0.80426-0","volume":"86","author":"R Suspene","year":"2005","unstructured":"Suspene R, Henry M, Guillot S, Wain-Hobson S, Vartanian JP (2005) Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR. J Gen Virol 86: 125\u2013129","journal-title":"J Gen Virol"},{"key":"BFEMBR201949568_CR68","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMra1810477","volume":"380","author":"DL Thomas","year":"2019","unstructured":"Thomas DL (2019) Global elimination of chronic hepatitis. N Engl J Med 380: 2041\u20132050","journal-title":"N Engl J Med"},{"key":"BFEMBR201949568_CR69","doi-asserted-by":"crossref","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","volume":"112","author":"P Tropberger","year":"2015","unstructured":"Tropberger P, Mercier A, Robinson M, Zhong W, Ganem DE, Holdorf M (2015) Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation. Proc Natl Acad Sci USA 112: E5715\u20135724","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201949568_CR70","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J (2016a) The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc 11: 2301\u20132319","journal-title":"Nat Protoc"},{"key":"BFEMBR201949568_CR71","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J (2016b) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13: 731\u2013740","journal-title":"Nat Methods"},{"key":"BFEMBR201949568_CR72","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1073\/pnas.252773599","volume":"100","author":"SL Uprichard","year":"2003","unstructured":"Uprichard SL, Wieland SF, Althage A, Chisari FV (2003) Transcriptional and posttranscriptional control of hepatitis B virus gene expression. Proc Natl Acad Sci USA 100: 1310\u20131315","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201949568_CR73","doi-asserted-by":"crossref","unstructured":"Van de Wiel S, Merkx M, Van de Graaf S (2016) Real time monitoring of intracellular bile acid dynamics using a genetically encoded FRET-based bile acid sensor. J Vis Exp e53659","DOI":"10.3791\/53659-v"},{"key":"BFEMBR201949568_CR74","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00209-18","volume":"3","author":"CM Weiss","year":"2018","unstructured":"Weiss CM, Trobaugh DW, Sun C, Lucas TM, Diamond MS, Ryman KD, Klimstra WB (2018) The interferon-induced exonuclease ISG20 exerts antiviral activity through upregulation of type I interferon response proteins. mSphere 3: e00209-18","journal-title":"mSphere"},{"key":"BFEMBR201949568_CR75","unstructured":"WHO (2019) Hepatitis B, Fact sheet, Updated 18 July 2019."},{"key":"BFEMBR201949568_CR76","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1073\/pnas.0504273102","volume":"102","author":"SF Wieland","year":"2005","unstructured":"Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV (2005) Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci USA 102: 9913\u20139917","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201949568_CR77","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","volume":"101","author":"S Wieland","year":"2004","unstructured":"Wieland S, Thimme R, Purcell RH, Chisari FV (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 101: 6669\u20136674","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201949568_CR78","volume":"15","author":"N Wu","year":"2019","unstructured":"Wu N, Nguyen X-N, Wang Li, Appourchaux R, Zhang C, Panthu B, Gruffat H, Journo C, Alais S, Qin J et al (2019) The interferon stimulated gene 20 protein (ISG20) is an innate defense antiviral factor that discriminates self versus non-self translation. PLoS Pathog 15: e1008093","journal-title":"PLoS Pathog"},{"key":"BFEMBR201949568_CR79","doi-asserted-by":"crossref","first-page":"104824","DOI":"10.1016\/j.antiviral.2020.104824","volume":"180","author":"Y Xia","year":"2020","unstructured":"Xia Y, Guo H (2020) Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential. Antiviral Res 180: 104824","journal-title":"Antiviral Res"},{"key":"BFEMBR201949568_CR80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/v9010018","volume":"9","author":"Y Xia","year":"2017","unstructured":"Xia Y, Protzer U (2017) Control of hepatitis B virus by cytokines. Viruses 9: 18","journal-title":"Viruses"},{"key":"BFEMBR201949568_CR81","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","volume":"150","author":"Y Xia","year":"2016","unstructured":"Xia Y, Stadler D, Lucifora J, Reisinger F, Webb D, Hosel M, Michler T, Wisskirchen K, Cheng X, Zhang K et al (2016) Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis. Gastroenterology 150: 194\u2013205","journal-title":"Gastroenterology"},{"key":"BFEMBR201949568_CR82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-6700-1_6","volume-title":"Hepatitis B virus: methods and protocols","author":"Y Xia","year":"2017","unstructured":"Xia Y, Stadler D, Ko C, Protzer U (2017) Analyses of HBV cccDNA quantification and modification. In Hepatitis B virus: methods and protocols, Guo H, Cuconati A (eds.), pp 59\u201372. New York, NY: Springer"},{"key":"BFEMBR201949568_CR83","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2893.2011.01471.x","volume":"19","author":"C Xiao","year":"2012","unstructured":"Xiao C, Qin B, Chen L, Liu H, Zhu Y, Lu X (2012) Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus. J Viral Hepatitis 19: e1\u201310","journal-title":"J Viral Hepatitis"},{"key":"BFEMBR201949568_CR84","doi-asserted-by":"crossref","first-page":"9332","DOI":"10.1128\/JVI.00918-10","volume":"84","author":"C Xu","year":"2010","unstructured":"Xu C, Guo H, Pan X-B, Mao R, Yu W, Xu X, Wei L, Chang J, Block TM, Guo J-T (2010) Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol 84: 9332\u20139340","journal-title":"J Virol"},{"key":"BFEMBR201949568_CR85","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/emboj\/cdg134","volume":"22","author":"K Yoshida","year":"2003","unstructured":"Yoshida K, Wang HG, Miki Y, Kufe D (2003) Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9. EMBO J 22: 1431\u20131441","journal-title":"EMBO J"},{"key":"BFEMBR201949568_CR86","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1073\/pnas.2033898100","volume":"100","author":"YY Zhang","year":"2003","unstructured":"Zhang YY, Zhang BH, Theele D, Litwin S, Toll E, Summers J (2003) Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc Natl Acad Sci USA 100: 12372\u201312377","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFEMBR201949568_CR87","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.30497","volume":"69","author":"L Zhou","year":"2019","unstructured":"Zhou L, Ren JH, Cheng ST, Xu HM, Chen WX, Chen DP, Wong VKW, Law BYK, Liu Y, Cai XF et al (2019) A functional variant in UBE2L3 contributes to HBV infection and maintains cccDNA stability by inducing degradation of APOBEC3A protein. Hepatology 69: 1885\u20131902","journal-title":"Hepatology"}],"container-title":["The EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.201949568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.15252\/embr.201949568","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.15252\/embr.201949568\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.embopress.org\/doi\/pdf\/10.15252\/embr.201949568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.15252\/embr.201949568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:45:56Z","timestamp":1779111956000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.15252\/embr.201949568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,9]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,4]]}},"alternative-id":["BFEMBR201949568"],"URL":"https:\/\/doi.org\/10.15252\/embr.201949568","relation":{},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,9]]},"assertion":[{"value":"30 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The position of Daniela Stadler was in part financed by a research grant from ALIOS BioPharma. Ulrike Protzer is shareholder and board member of SCG Cell Therapy. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"EMBR201949568"}}